Skip to contentApplication 078803
- Type
- ANDA
- Sponsor
- ACTAVIS TOTOWA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | OXALIPLATIN | OXALIPLATIN | INJECTABLE;INTRAVENOUS | 50MG/VIAL | No | Yes |
| 002 | OXALIPLATIN | OXALIPLATIN | INJECTABLE;INTRAVENOUS | 100MG/VIAL | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 45963-611 | Oxaliplatin | Oxaliplatin | Actavis Pharma, Inc. | ANDA | Current |
| 45963-611 | Oxaliplatin | Oxaliplatin | Actavis Pharma, Inc. | ANDA | Current |
| 45963-611 | Oxaliplatin | Oxaliplatin | Actavis Pharma, Inc. | ANDA | Current |
| 45963-611 | Oxaliplatin | Oxaliplatin | Actavis Pharma, Inc. | ANDA | Current |
| 45963-611 | Oxaliplatin | Oxaliplatin | Actavis Pharma, Inc. | ANDA | Current |